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Abstract
Background: There is an increasing drive to replace fish oil (FO) in finfish aquaculture diets with
vegetable oils (VO), driven by the short supply of FO derived from wild fish stocks. However, little
is known of the consequences for fish health after such substitution. The effect of dietary VO on
hepatic gene expression, lipid composition and growth was determined in Atlantic salmon (Salmo
salar), using a combination of cDNA microarray, lipid, and biochemical analysis. FO was replaced
with VO, added to diets as rapeseed (RO), soybean (SO) or linseed (LO) oils.
Results: Dietary VO had no major effect on growth of the fish, but increased the whole fish
protein contents and tended to decrease whole fish lipid content, thus increasing the protein:lipid
ratio. Expression levels of genes of the highly unsaturated fatty acid (HUFA) and cholesterol
biosynthetic pathways were increased in all vegetable oil diets as was SREBP2, a master
transcriptional regulator of these pathways. Other genes whose expression was increased by
feeding VO included those of NADPH generation, lipid transport, peroxisomal fatty acid oxidation,
a marker of intracellular lipid accumulation, and protein and RNA processing. Consistent with
these results, HUFA biosynthesis, hepatic β-oxidation activity and enzymic NADPH production
were changed by VO, and there was a trend for increased hepatic lipid in LO and SO diets. Tissue
cholesterol levels in VO fed fish were the same as animals fed FO, whereas fatty acid composition
of the tissues largely reflected those of the diets and was marked by enrichment of 18 carbon fatty
acids and reductions in 20 and 22 carbon HUFA.
Conclusion: This combined gene expression, compositional and metabolic study demonstrates
that major lipid metabolic effects occur after replacing FO with VO in salmon diets. These effects
are most likely mediated by SREBP2, which responds to reductions in dietary cholesterol. These
changes are sufficient to maintain whole body cholesterol levels but not HUFA levels.
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FO has been, and still remains, the principal lipid source
for fish diets in intensive aquaculture[1]. Because the wild
fisheries, from which FO is obtained, are currently fished
to the maximal sustainable levels there is pressure to uti-
lise alternative lipid sources in aquaculture diets. Cur-
rently the most practical alternatives are VOs and recent
studies have demonstrated that VO can be used to replace
up to 75% of FO without significant effects on growth in
Atlantic salmon [2]. However the effects of VO-based diets
on normal metabolism and physiology and ultimately
fish health and welfare are not yet understood. A variety
of potentially deleterious effects have been reported in
VO-fed fish. These include cardiac lesions [3], liver his-
topathology [4], compromised immune function [5] and
disruption of intestinal function [6-9]. There is good rea-
son to suspect that feeding of VO may have a major
impact on fish physiology since VO differ considerably in
composition compared to FO. For example VOs are rich
in shorter chain, C18 polyunsaturated fatty acids (PUFA)
and devoid of n-3HUFA. Indeed, fatty acid compositions
in fish, including salmon, fed VO are characterised by
increased levels of C18 PUFA and decreased levels of n-
3HUFA, which could compromise their nutritional value
to the human consumer [2,10].
Massively parallel gene expression profiling technologies
such as cDNA or oligonucleotide microarrays are power-
ful tools for discovering genes which change their tissue or
cellular expression levels in response to changed condi-
tions and thence enable the physiological mechanisms
underlying such changes to be elucidated. Until recently
there have been few such resources for commercially
important fish species. The recent development of high
density cDNA microarrays for Atlantic salmon (GRASP;
TRAITS-SGP; [11,12], the most commercially valuable
farmed fish species in Europe and the Americas, has
opened the way for fundamental studies on diet-gene
interactions and promises to greatly advance understand-
ing of fish nutrition.
The aim of this study was to discover mechanisms for
physiological adaptation to VO-based diets in fish. This
was achieved by measuring the effects on hepatic gene
expression using a high density cDNA microarray, and by
complementary biochemical and compositional assays of
Atlantic salmon smolts fed diets in which 100% of the FO
was replaced with three VOs, rapeseed oil (RO), linseed
oil (LO) or soybean oil (SO).
Results
Growth and biometry
Slightly, but significantly, lower final weights were
obtained with fish fed the LO diets compared to fish fed
FO (Table 1). However, no effect of dietary oil was
observed in the specific growth rate (SGR) obtained for
individually pit-tagged fish. Dietary VOs had no effect on
feed efficiency as measured by feed conversion ratio
(FCR), hepato-somatic index (HSI) or viscero-somatic
index (VSI) or condition factor (Table 1).
Proximate, lipid and fatty acid compositions
All the VO diets significantly increased the relative per-
centage of protein in the whole fish compared to fish fed
Table 1: Growth, biometric parameters and proximate analyses for Atlantic salmon (Salmo salar) fed the experimental diets for 16 
weeks
FO LO RO SO
Initial weight (g) 132.0 ± 12.3 132.4 ± 12.6 132.1 ± 12.8 131.3 ± 12.2
Final weight (g) 434.5 ± 64.1ab 412.9 ± 61.8c 447.4 ± 75.6a 419.7 ± 67.8bc
SGR 1.03 0.99 1.06 1.01
SGR (Pit-tags) 1.09 ± 0.14 1.07 ± 0.11 1.16 ± 0.10 1.1 ± 0.13
FCR 0.72 0.75 0.71 0.71
VSI 8.60 ± 0.70 8.92 ± 0.86 8.65 ± 0.72 9.06 ± 0.94
HSI 1.19 ± 0.14 1.10 ± 0.16 1.13 ± 0.15 1.14 ± 0.12
CF initial 1.05 ± 0.07 1.06 ± 0.05 1.04 ± 0.06 1.04 ± 0.07
CF final 1.24 ± 0.11 1.25 ± 0.10 1.27 ± 0.12 1.24 ± 0.12
Moisture 65.50 ± 0.80 66.80 ± 1.80 66.50 ± 0.60 68.10 ± 0.80
Protein 51.00 ± 0.50b 55.10 ± 1.70a 53.90 ± 1.30a 55.60 ± 0.30a
Lipid 40.50 ± 0.20a 35.80 ± 2.50b 38.30 ± 1.50ab 37.10 ± 0.20ab
Ash 5.70 ± 0.10b 6.30 ± 0.30a 5.90 ± 0.20ab 6.30 ± 0.20a
P/L Ratio 1.28 ± 0.02b 1.40 ± 0.14ab 1.32 ± 0.08ab 1.49 ± 0.01a
Initial and final weights (n = 250), SGR (pit-tags) (n = 20), VSI (n = 12), HSI (n = 12) and CF (n = 12) Moisture, Protein, Lipid, Ash (n = 3) are all 
means ± SD. Significance of differences between means were determined by one -way ANOVA followed, where appropriate, by Tukey's multiple 
comparison test as described in the Materials and Methods. Values within a row with a different superscript letter are significantly different (P ≤ 
0.05). CF, condition factor = 100 × [(body weight (g)/body length (cm)]3; FCR, feed conversion ratio = feed consumed (kg)/weight gain (kg); HSI, 
hepato-somatic index = 100 × (liver weight × body weight-1); SGR, specific growth rate (%/day) = 100 × [(ln weight final – ln weight initial) × days-
1]; VSI, viscero-somatic index = 100 × (carcass weight × body weight-1). P/L, Protein:Lipid ratio.Page 2 of 15
(page number not for citation purposes)
BMC Genomics 2008, 9:299 http://www.biomedcentral.com/1471-2164/9/299the FO diet (Table 1). There was also a tendency for the
VO diets to decrease whole body lipid, and increase the
protein:lipid ratio although these parameters were only
significant in fish fed LO (Table 1). Liver total lipid con-
tent was not significantly affected by dietary VOs, but
there was a trend towards increased free fatty acids in fish
fed LO and increased total neutral lipid and triacylglycerol
in fish fed SO and LO (Table 2). Dietary VO had only a
few significant effects on the lipid class composition of
liver with the most obvious being fish fed LO and SO
showing reduced proportions of phosphatidyleth-
anolamine compared to fish fed FO (Table 2). Differences
in phosphatidylcholine levels were also observed between
RO and LO, although none of the VO diets showed signif-
icant differences compared to FO. Increases in total
unknown neutral lipid were also apparent in RO and SO
fed fish compared to FO. In general the fatty acid compo-
sitions of liver and flesh total lipid (Table 3) reflected the
fatty acid compositions of the diets. Thus fish fed the FO
diet were characterised by high levels of 16:0, 20:5n-3
(eicosapentaenoic acid; EPA) and 22:6n-3 (docosahexae-
noic acid; DHA), with 20:4n-6 (arachidonic acid; ARA) as
the major n-6 fatty acid. Feeding the VOs resulted in
increased proportions of 18:1n-9 and total monoenes,
18:2n-6 and total n-6PUFA, and 18:3n-3, and decreased
the proportions of 16:0 and total saturated fatty acids,
ARA, EPA and DHA. Specifically, the major fatty acids in
fish fed RO, SO and LO were 18:1n-9, 18:2n-6 and 18:3n-
3, respectively. Fish fed the vegetable oils also showed
increased proportions of the metabolites of these fatty
acids, namely 20:3n-3 and 20:4n-3 in fish fed LO, 20:2n-
6 and 20:3n-6 in fish fed SO, and 20:1n-9 in fish fed RO.
Liver enzyme activities
No effect of diet was detected on the activity of liver carni-
tine palmitoyl transferase 1 (CPT1) activity, although fatty
acid β-oxidation was increased in LO and RO fed fish.
HUFA synthesis was increased in liver microsomes from
fish fed all the VOs compared to fish fed FO. The activity
of malic enzyme (ME) was increased in fish fed the RO
diet in comparison to fish fed FO (Fig. 1).
Microarray gene expression profiling
Comparison of each experimental diet to FO identified
428, 350 and 434 features from RO, LO and SO respec-
tively which were significantly different (p ≤ 0.05). These
lists from each VO were then compared and features
which were significantly changed relative to FO in two or
more VO diets (T-test, P ≤ 0.05) were retained. This
resulted in a list of 132 features. Features were then elim-
inated which were changed in different directions in dif-
ferent VO diets, resulting in a list of 128 features, 88 of
which could be tentatively identified according to BLAST
results. These genes whose expression was changed, and
whose identity could be indicated from BLAST similarity,
in two or more VO diets compared to FO, are listed in
Table 4.
Gene ontology (GO) terms for biological processes were
available for 39 of the 88 features with significant BLAST
similarities that were changed in VO diets. The biological
process GO terms associated with these 39 genes were
compared with the total GO list for the TRAITS/SGP, and
tested for significant (p ≤ 0.05) overrepresentation as
implemented in GeneSpring GX 7.3.1 (Agilent). Only GO
categories represented by more than one gene from the
Table 2: Lipid class composition of liver of Atlantic salmon (Salmo salar) fed various dietary oils
Lipid class FO LO RO SO
Total lipid 4.2 ± 0.2 4.8 ± 0.5 4.4 ± 0.5 4.8 ± 0.8
Phosphatidylcholine 17.7 ± 4.0ab 13.3 ± 0.5b 19.0 ± 1.6a 14.5 ± 0.8ab
Phosphatidylethanolamine 10.1 ± 1.5a 7.7 ± 1.2b 9.4 ± 0.7ab 7.8 ± 0.6b
Phosphatidylserine 2.6 ± 1.3 3.1 ± 0.5 3.7 ± 0.4 3.1 ± 0.5
Phosphatidylinositol 3.2 ± 1.4 2.8 ± 0.8 4.0 ± 0.3 3.4 ± 0.5
PG/CL 3.2 ± 0.9 2.2 ± 1.1 2.6 ± 0.3 1.8 ± 0.4
Sphingomyelin 1.8 ± 0.3 1.4 ± 0.3 1.8 ± 0.2 1.4 ± 0.3
Lyso-PC 2.8 ± 0.2 2.7 ± 0.4 2.2 ± 0.5 1.9 ± 0.4
Unknown polar lipid 2.0 ± 0.3 2.5 ± 0.2 3.2 ± 0.2 2.8 ± 0.3
Total polar 43.4 ± 6.9ab 35.7 ± 0.6b 45.8 ± 3.9a 36.8 ± 3.2ab
Total neutral 56.6 ± 6.9ab 64.3 ± 0.6a 54.2 ± 3.9b 63.2 ± 3.2ab
Cholesterol 15.9 ± 0.9 15.7 ± 1.0 16.0 ± 0.8 15.3 ± 0.5
Triacylglycerol 24.8 ± 7.8 29.4 ± 2.2 23.1 ± 3.5 28.3 ± 2.4
Free fatty acid 7.7 ± 2.3 12.1 ± 1.8 8.0 ± 4.0 10.4 ± 0.8
Steryl ester 6.9 ± 2.1 5.6 ± 2.2 3.8 ± 1.3 5.6 ± 1.9
Unknown neutral lipid 1.3 ± 0.9b 1.4 ± 0.8b 3.3 ± 0.5a 3.6 ± 0.6a
Values are means ± SD of 4 samples each of tissue pooled from 3 fish. Significance of differences between means were determined by one-way 
ANOVA followed, where appropriate, by Tukeys multiple comparison post hoc test. Values within a row with a different superscript letter are 
significantly different (P ≤ 0.05). CL, cardiolipin; Lyso-PC, lysophosphatidylcholine; PG, phosphatidylglycerol. All values are expressed as percentage 
total lipid, except total lipid which is expressed as percentage of wet weight.Page 3 of 15
(page number not for citation purposes)
BMC Genomics 2008, 9:299 http://www.biomedcentral.com/1471-2164/9/299final gene list were considered significant and are reported
in Table 5. Overrepresented GO categories included lipid
metabolism, sterol biosynthesis, isoprenoid biosynthesis,
fatty acid desaturation, mRNA processing, and transla-
tional elongation. It should be noted that the current gene
ontology annotations (biological process) for the TRAITS/
SGP array are only available for 3921 of the 16950 fea-
tures. Notably amongst those genes in the final list which
were overrepresented after GO analysis, were genes show-
ing the greatest increase in expression. These included Δ5/
6 fatty acyl desaturases which function in HUFA biosyn-
thesis (enriched GO:6636, fatty acid desaturation) and
isopentenyl-diphosphate Δisomerase (IPP), lathosterol
oxidase, and squalene epoxidase, all genes of the choles-
terol biosynthesis pathway (enriched GO:8299, isopre-
noid biosynthesis; GO6695, cholesterol biosynthesis).
Levels of other genes associated with lipid metabolism
(enriched GO: 6629) or transport were also changed.
These included increases in apoliporotein B (apoB) and
decreases in an apoB-like gene in LO and SO. Effects were
seen in levels of expression of genes involved in transcrip-
tion, RNA processing and translation (enriched
GO:6414).
Many of the remaining genes from the final list could also
be grouped into distinct biological process categories,
although they were not identified as such by GO analysis.
Changes in carbohydrate metabolism genes included an
increase in the expression of glycogen phosphorylase in
all VO, and glucose 6-phosphate dehydrogenase in SO
and RO. Several changes in expression levels of genes of
protein degradation associated with the ubiquitin-proteo-
some pathway were observed, and also in the protease
calpain1 which was upregulated more than five fold in all
VO. Signal transduction genes were also changed and
MARCKS-like 1 was increased in all VO treatments and
protein phosphatase 1β decreased in all VO treatments.
Genes for proteins with extracellular locations which
changed in VO included the protease inhibitors cystatin,
spint2 and tissue factor pathway inhibitor 2, as well as
decreased expression of collagen1A3. In addition there
were 44 features changed by VO for which no identity
could be confirmed by BLAST (not shown).
Quantitative PCR (QPCR)
Results for QPCR are presented in Table 6. Three genes of
the cholesterol biosynthesis pathway were upregulated in
Table 3: Fatty acid composition (percentage of weight) of total lipid from livers of Atlantic salmon (Salmo salar) fed different dietary 
oils
FO LO RO SO
14:0 2.7 ± 0.4a 0.6 ± 0.0b 1.0 ± 0.1b 0.6 ± 0.0b
16:0 16.7 ± 0.8a 10.0 ± 0.8b 12.1 ± 1.0b 11.4 ± 1.3b
18:0 5.9 ± 0.4a 6.0 ± 0.4a 4.4 ± 0.2b 6.1 ± 0.4a
Total saturated1 25.8 ± 0.5a 16.9 ± 1.0b 17.9 ± 0.9b 18.4 ± 1.2b
16:12 3.7 ± 0.6a 1.0 ± 0.1c 1.8 ± 0.1b 0.9 ± 0.1c
18:1n-9 9.3 ± 1.1c 18.4 ± 1.7b 29.1 ± 2.0a 18.4 ± 2.2b
18:1n-7 2.9 ± 0.1a 1.1 ± 0.1d 2.4 ± 0.1b 1.6 ± 0.1c
20:13 2.5 ± 0.4b 2.0 ± 0.1b 3.8 ± 0.4a 2.2 ± 0.2b
22:14 1.0 ± 0.4 0.8 ± 0.1 1.0 ± 0.2 0.6 ± 0.1
24:1n-9 1.0 ± 0.1a 0.6 ± 0.1b 0.8 ± 0.1ab 0.6 ± 0.1b
Total monoenes 20.3 ± 2.6b 24.0 ± 1.9b 39.0 ± 2.5a 24.3 ± 2.4b
18:2n-6 1.9 ± 0.4c 9.6 ± 0.3b 8.6 ± 0.3b 26.4 ± 1.8a
20:2n-6 0.5 ± 0.0c 1.4 ± 0.1b 1.6 ± 0.1b 4.3 ± 0.2a
20:3n-6 0.3 ± 0.1d 0.6 ± 0.1c 1.1 ± 0.1b 2.5 ± 0.1a
20:4n-6 2.8 ± 0.4a 0.7 ± 0.1c 1.4 ± 0.2b 1.6 ± 0.2b
Total n-6 PUFA5 6.4 ± 0.1c 12.5 ± 0.3b 13.1 ± 0.1b 35.3 ± 1.7a
18:3n-3 0.6 ± 0.2c 20.3 ± 0.9a 2.4 ± 0.2b 2.3 ± 0.1b
18:4n-3 0.6 ± 0.3a 0.8 ± 0.1a 0.3 ± 0.1b 0.2 ± 0.0b
20:3n-3 0.2 ± 0.1b 3.2 ± 0.3a 0.4 ± 0.1b 0.3 ± 0.0b
20:4n-3 1.2 ± 0.3b 3.0 ± 0.0a 1.0 ± 0.1b 0.6 ± 0.1c
20:5n-3 10.7 ± 0.3a 4.0 ± 0.4b 4.8 ± 0.4b 2.6 ± 0.6c
22:5n-3 3.6 ± 0.0a 1.0 ± 0.1c 1.4 ± 0.1b 0.8 ± 0.2c
22:6n-3 30.0 ± 2.7a 14.3 ± 1.6c 19.6 ± 1.8b 15.2 ± 2.3c
Total n-3 PUFA 46.9 ± 2.2a 46.6 ± 1.7a 30.0 ± 1.8b 22.0 ± 3.0c
Total PUFA 54.0 ± 2.2b 59.1 ± 1.6a 43.1 ± 1.7c 57.3 ± 1.5ab
Values are means ± SD of 4 samples each of tissue pooled from 3 fish. Significance of differences between means were determined by one-way 
ANOVA followed, where appropriate, by Tukey's multiple comparison test as described in the Materials and Methods. Values within a row with a 
different superscript letter are significantly different (P ≤ 0.05). 1, contains 15:0, 20:0 and 22:0, present in some samples at up to 0.4%; 2, 
predominantly n-7 isomer; 3, predominantly n-9 isomer; 4, predominantly n-11 isomer; 5, totals include 18:3n-6, 22:4n-6 and 22:5n-6 present in 
some samples at up to 0.5%.Page 4 of 15
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array features, was selected for QPCR, another 7-dehydro-
cholesterol reductase was also on the array but was not
significantly changed (p = 0.07). A further two genes,
mevalonate kinase (MK) and SREBP2 were selected for
QPCR because they were not present on the microarray,
but were identified in BLAST searches of Atlantic salmon
EST collections. MK was upregulated in all three VO,
whilst SREBP2 mRNA was significantly increased in LO
and RO, although not in SO (p = 0.057). HMG-CoA
reductase (HMGR), another gene in the cholesterol bio-
synthesis pathway was not changed, either on the basis of
microarray data or by QPCR. Δ6 fatty-acyl desaturase
mRNA was also confirmed by QPCR to increase in all VO
diets. A number of other lipid metabolic genes, selected
on the basis of the microarray data were also assayed by
QPCR. QPCR confirmed the microarray result that carni-
tine palmitoyl transferase A (CPT1A) mRNA was not
changed, whilst QPCR of apolipoprotein B mRNA
(APOB) demonstrated upregulation in LO and RO,
whereas the array results indicated upregulation in SO
and LO. Three other genes (catalase, PPARβ and short
chain alcohol dehydrogenase) whose expression was not
different between FO and VO by array analysis were also
confirmed not to be changed after QPCR. However PPARγ
which showed altered expression levels on micorarray
analysis was not changed as measured by QPCR.
Discussion
Although there were some relatively small differences, no
great effects of diet on growth were observed in the
present trial. Nevertheless, the effects of diet on tissue fatty
acid composition are very clear with VO having highly sig-
nificant effects. These effects are as expected and as
reported in several previous trials on salmon [10,13,14].
As a means of more fully investigating the possible effects
of VO substitution, liver was chosen to undertake a gene
expression profiling experiment using the recently devel-
oped TRAITS/SGP microarray for Atlantic salmon. Liver
integrates a large part of the nutritional uptake from the
diet and has particular roles in distributing dietary lipid,
and synthesising lipid de novo as well as participating in
detoxification and excretion pathways. The use of high
density cDNA microarrays is now a well established
method, and we sought to use the TRAITS/SGP array to
discover genes, and indicate biochemical and physiologi-
cal pathways whose expression patterns might change
during adaptation to VO-based diets. In this DNA micro-
array hybridisation experiment, application of ANOVA
indicated that 784 features were changed at p ≤ 0.05
across all diet groups. However, application of either mul-
tiple testing correction (Benjamini and Hochberg) or a
post hoc test (Tukeys multiple comparison) reduced this
list of features 50 fold. Nevertheless, it was apparent that
amongst the features from the list generated by ANOVA
which passed filters for multiple testing correction or post
hoc testing, were genes for Δ5/Δ6 fatty acyl desaturases.
Given that these desaturase genes were known from prior
experiments to be up-regulated in VO fed salmon [15] we
filtered genes according to the criteria of having expres-
sion changed in the same direction in two or more of the
VO dietary conditions after individual t-tests. In support
of this approach it is notable that of the 132 genes which
were scored as being changed in two or more VO diets,
only 4 showed expression changes in opposite directions,
far less than would be expected by chance alone. We
tested the validity of the list of commonly changed candi-
dates by a combination of compositional, biochemical
and independent gene expression measurement by QPCR.
The overall consistency of gene expression and physiolog-
ical data demonstrates the validity of our approach to
interpreting the microarray results presented here.
The most consistently and highly up-regulated genes that
could be identified by homology or had previously been
characterised and were clearly overrepresented after GO
analysis were those of the Δ5 and Δ6 fatty acyl desaturases.
Desaturases are encoded by several genes in salmon and
each of them were represented on the array. Every one of
these showed significant up-regulation in two or more of
the VO diets. QPCR confirmed that desaturase mRNAs
were increased and in addition the biosynthesis of HUFA
Expression of various enzyme activities in vegetable oil fed Atlantic salmonFigure 1
Expression of various enzyme activities in vegetable 
oil fed Atlantic salmon. Results are expressed relative to 
fish oil. Those which are significantly different from fish oil (p 
≤ 0.05 t-test) are indicated with an asterisk. BOX, total 
palmitoyl CoA beta-oxidation; CPT1, carnitine palmitoyl 
CoA transferase; HUFA, highly unsaturated fatty acid synthe-
sis; ME, malic enzyme. Specific enzyme activities for control 
fish are: BOX, 33.6 ± 4.7 pmol palmitoyl-CoA oxidised/min/
mg protein; CPT1, 56.7 ± 14.8 pmol palmitoyl-carnitine pro-
duced/min/mg protein; HUFA, 2.88 ± 0.1 pmol linolenic acid 
desaturation products/h/mg protein; ME, 69.8 ± 15.2 nmol 
malate oxidised/min/mg protein.Page 5 of 15
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PROCESS ACC. NO. LO RO SO EST-BLASTX OR EST-TC-BLASTX
HUFA BIOSYNTHESIS DW588445 4.131 6.1 3.529 (Q9DEX7) Delta-5/delta-6 fatty acid desaturase
EG354827 3.814 3.864 0.685 (AAL82631) Salmon delta-5 fatty acyl desaturase, 
TC51151
EG647320 4.286 3.37 1.909 (Q9DEX7) Delta-5/delta-6 fatty acid desaturase
AAL82631 5.624 11.29 8.027 (Q9DEX7) Delta-5/delta-6 fatty acid desaturase
AAL82631 1.84 3.657 2.932 (Q9DEX7) Delta-5/delta-6 fatty acid desaturase
AAR21624 2.564 4.248 2.688 (Q9DEX7) Delta-5/delta-6 fatty acid desaturase
CHOLESTEROL AND ISOPRENOID 
BOSYNTHESIS
CK875291 13.61 12.23 13.86 (O35760) Isopentenyl-diphosphate delta-isomerase 1
CO471940 6.282 8.078 6.958 (Q4R4W5) Isopentenyl-diphosphate delta-isomerase 1
EG647637 14.11 2.921 20.59 (P52019) squalene epoxidase
CK874989 4.679 4.488 3.376 (O88822) Lathosterol oxidase
CK881623 1.132 0.762 0.764 (O42563) Cytochrome P450 3A27
LIPID METABOLISM AND TRANSPORT NAN 1.494 1.881 1.613 (CAA57449) apolipoprotein B [Salmo salar], TC40920
AM042514 1.085 1.84 1.618 (Q96BZ4) PLD4 phospholipase D family, member 4, 
TC47857
DW589827 1.403 0.968 1.27 (P59837) Retinol dehydrogenase 12
BF228485 0.841 0.752 1.228 (Q9R182) Angiopoietin-related protein 3
NAN. 0.489 0.709 0.652 (Q9BYV7) BCDO2 Beta-carotene dioxygenase 2
AJ416951 0.541 0.696 0.799 (O88275) Peroxisome proliferator-activated receptor 
gamma
AM402843 0.362 0.67 0.441 (Q5TZ29) Novel protein similar to vertebrate 
apolipoprotein B
CARBOHYDRATE METABOLISM CK880626 1.093 1.816 2.013 (P05370) G6PD Glucose-6-phosphate 1-dehydrogenase
AM083390 2.685 1.291 1.873 (Q5MIB6) Glycogen phosphorylase
NAN 2.316 1.609 1.256 (Q04760) GLO1 glyoxalase 1, TC39739
EG355381 0.47 0.659 0.7 (P15121) AKR1B1 aldo-keto reductase 1B1, TC40780
MITOCHONDRIAL FUNCTION DW589236 8.96 2.524 1.84 (Q96EL2) MRPS24 mitochondrial ribosomal protein S24, 
TC34551
CK891719 3.013 2.495 2.212 (Q99595) Mitochondrial import inner membrane 
translocase Tim17 A
NAN 2.067 1.455 1.582 (Q9EQ20) aldh6a1 aldehyde dehydrogenase 6A1, 
TC37457
CK881059 0.97 0.515 0.587 (Q9H2U2) Inorganic pyrophosphatase 2, mitochondrial
EG649042 2.754 0.644 0.763 (P16036) Phosphate carrier protein, mitochondrial
PROTEIN PROCESSING AND TURNOVER CK898137 2.407 1.258 1.377 (Q5ZIJ9) Ubiquitin ligase protein MIB2
CK878932 2.384 1.532 1.599 (P03974) Transitional endoplasmic reticulum ATPase
BM414061 5.083 5.299 5.287 (P97571) Calpain-1 catalytic subunit
CK893924 1.906 1.819 2.368 (Q99614) Tetratricopeptide repeat protein 1
DW591059 1.6 1.198 1.72 (ABQ57500) small heat shock protein HSPB9, TC57595
AM397488 0.357 0.941 0.517 (P45878) FK506-binding protein 2, TC38192
RNA PROCESSING CK888026 1.133 1.293 1.791 (P09651) heterogeneous nuclear ribonucleoprotein A1, 
TC61954
CK892099 2.289 1.389 1.697 (P28048) La ribonucleoprotein A
DW588498 1.629 1.995 2.155 (Q9D198) syf2 SYF2 homolog, RNA splicing factor, 
TC34249
CK891976 1.222 1.093 1.373 (Q6PDM2) sfrs1 splicing factor, arginine/serine-rich 1, 
DY729372
DW589408 0.538 0.625 0.56 (Q9D0E1) heterogeneous nuclear ribonucleoprotein M, 
TC35947
CK884048 1.354 0.792 0.874 (P62317) Small nuclear ribonucleoprotein Sm D2
AJ425602 0.526 0.481 0.578 (Q5RF83) Cold-inducible RNA-binding proteinPage 6 of 15
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G(T) beta1
CK881679 2.84 1.823 2.093 (Q8JGT0) Casein kinase I alpha, TC40170
NAN 0.531 0.637 0.812 (Q8BXH3) gucy1b2 guanylate cyclase 1, soluble, beta 2, 
TC44944
CK879754 0.333 0.627 0.428 (Q14511) Enhancer of filamentation 1
CK877929 0.877 0.528 0.416 (Q2M5E4) RGS21 regulator of G-protein signaling 21, 
TC38138
CK884662 0.258 0.521 0.539 (P62142) Serine/threonine protein phosphatase PP1b 
catalytic
AM049833 0.603 0.862 0.689 (P62155) Calmodulin
BF228513 0.402 0.506 0.682 (Q8CFJ8) par-6 partitioning defective 6 homolog gamma, 
BF228513
TRANSCRIPTION CN181085 1.588 1.189 1.597 (Q8BQ46) TAF15 RNA polymerase II, TC53593
EG648659 1.637 1.396 1.09 (Q6GPQ6) Endothelial differentiation-related factor 1 
homolog
AM402809 1.363 1.469 1.242 (Q8BG15) ctdspl2 CTD small phosphatase like 2
CK898087 0.698 0.627 0.699 (Q9ERU2) Zinc finger protein 22
TRANSLATION DW588363 1.032 1.227 1.414 (P17508) Elongation factor 1-alpha, oocyte form
EG648663 1.305 1.076 1.433 (Q9WV70) Nucleolar complex protein 2 homolog
NAN 1.974 1.225 1.812 (P18077) RPL35a ribosomal protein L35a, TC60182
EG647766 0.695 0.74 0.933 (P47826) 60S acidic ribosomal protein P0
CK886497 0.559 0.688 0.854 (P57776) Elongation factor 1-delta
EXTRACELLULAR MATRIX CK877333 1.554 2.258 2.234 (Q98967) Cystatin
CK876354 0.869 0.671 0.631 (Q5D0F2) serine protease inhibitor, Kunitz type, 2, 
TC52802
AM042526 0.534 0.888 0.45 (P48307) TFPI2 tissue factor pathway inhibitor 2, 
TC51552
CK885060 0.386 0.419 0.476 (BAB55662) collagen a3(I), TC58897
AJ424854 0.432 0.483 0.776 (O93486) Alpha 3 type I collagen, TC43437
AJ425530 0.191 0.466 0.554 (Q9JM06) EGF- fibulin-like extracellular matrix protein 2, 
TC48959
IMMUNE FUNCTION AM042172 1.456 0.444 0.472 (AAW66975) Ig mu heavy chain secretory form, 
TC58483
AM397498 0.075 0.667 0.446 (P08603) Complement factor H
ION TRANSPORT AM402718 0.464 0.561 1.19 (Q9NYB5) solute carrier organic anion transporter 1C1, 
TC47786
CK885259 0.484 0.625 0.746 (Q9YH26) Sodium/potassium-transporting ATPase alpha-
1 chain
AM402711 0.225 0.743 0.369 (Q28677) Solute carrier family 12 member 4
APOPTOSIS CK879455 0.432 0.616 0.587 (O18998) Deoxyribonuclease-1
GROWTH AND PROLIFERATION EG649002 1.157 1.746 1.278 (Q5R5D0) Cyclin-G1
CK876621 0.74 1.594 1.492 (Q80UU6) ogfr opioid growth factor receptor, TC55122
CYTOSKELETON EG647322 4.417 4.16 2.259 (P49006) MARCKS-like 1, TC40754
DW588815 0.518 0.609 0.831 (P68372) Tubulin beta-? Chain
LYSOSOMAL AM042088 0.598 0.579 0.583 (Q90744) Alpha-N-acetylgalactosaminidase
AA BIOSYNTH CK890942 0.545 0.671 0.727 (A6H5Y3) mtr methionine synthase, TC52579
MUSCLE DW591140 1.938 1.327 1.268 (P06741) MYL1 myosin, light chain 1, TC60893
RESPIRATION EG648831 0.467 0.426 0.386 (P02142) Hemoglobin beta-1 subunit
Table 4: Genes in liver changed in two or more vegetable oil diets compared to salmon fed fish oil (Continued)Page 7 of 15
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BMC Genomics 2008, 9:299 http://www.biomedcentral.com/1471-2164/9/299UNKNOWN FUNCTION EG647376 0.26 1.808 1.739 (XP_691559) hypothetical protein [Danio rerio], 
TC35542
NAN 0.93 1.98 1.353 (XP_001340266) hypothetical protein [Danio rerio], 
TC45154
AM042055 1.284 1.242 1.75 (Q6I9Y2) THOC7 THO complex 7 homolog, TC54560
AM402609 2.644 2.732 1.84 (Q56TU0) Type-4 ice-structuring protein precursor, 
TC59473
CK898312 1.492 1.959 2.192 (XP_692475) similar to CG6282-PA, isoform A, TC34514
CK897369 0.705 0.732 0.677 (Q5JVS0) HABP4 hyaluronan binding protein 4, TC34600
CK881591 0.288 0.295 0.408 (XP_001338932) hypothetical protein [Danio rerio], 
TC55348
BM414217 0.655 0.969 0.709 (XP_708731) hypothetical protein isoform 2, TC55763
TRANSPOSON EG647536 0.993 1.841 1.305 (XP_001341934) similar to ReO_6, retrotransposon, 
TC63376
EG647893 0.318 0.428 0.423 (AAW27349) SJCHGC04625 protein, retrotransposon, 
TC46087
BM414246 0.907 0.525 0.54 (ABV31711) transposase, TC43560
CK879027 0.76 0.985 0.683 (Q04202) Transposable element Tcb2 transposase
Numbers indicate expression ratio and a significant change (VO:FO; T-test, p ≤ 0.05) is indicated by bold type. LO, linseed oil; SO, soyabean oil; 
RO, rapeseed oil. Accession numbers of array features are provided. TC numbers are also provided, as described in text.
Table 4: Genes in liver changed in two or more vegetable oil diets compared to salmon fed fish oil (Continued)was increased in liver microsomes from VO-fed fish. How-
ever, despite this clear increase in desaturase mRNA and
HUFA biosynthesis, the amount of HUFA in salmon tis-
sue was still considerably reduced when FO was replaced
by VO in the diet. These results confirm previous reports
describing the expression of salmon Δ5/Δ6 desaturase,
where feeding of VO has been shown to increase desatu-
rase expression and HUFA biosynthesis [15,16].
In addition to the increase in fatty acyl desaturase expres-
sion, increases in mRNA for three enzymes (IPP, squalene
epoxidase and lathosterol oxidase) of the cholesterol bio-
synthetic pathway were also evident from microarray data
and from QPCR for IPP. To test the hypothesis that the
cholesterol biosynthetic pathway was up-regulated fol-
lowing VO feeding the Atlantic salmon EST collections
were searched for genes which are known to participate in
cholesterol biosynthesis, but were not present on the
TRAITS/SGP array. Two genes were identified and assayed
by QPCR, MK and SREBP2. MK is known to be highly reg-
ulated by cholesterol level in mammalian liver and
SREBP2 is a master transcriptional regulator of both cho-
lesterol and HUFA biosynthesis [17]. Messenger RNA for
both of these genes was increased by a similar amount to
that seen for IPP. The activity of SREBP2 is controlled by
cellular cholesterol status, such that reductions in mem-
brane cholesterol trigger proteolytic cleavage of mem-
brane bound SREBP2 and lead to its translocation to the
nucleus where it drives the transcription of the genes for
cholesterol and HUFA biosynthesis [17]. Of the 12 genes
involved in lipid metabolism which were changed on the
microarray after feeding VO, 5 are known to be regulated
by SREBPs (Δ5 desaturase, Δ6 deasturase, IPP, lathosterol
oxidase and squalene epoxidase) [17]. Another gene in
the cholesterol biosynthesis pathway, 7-dehydrocholes-
terol reductase, which by QPCR was upregulated in all
VO, was on present the TRAITS-SGP array, but was not
present in the final output gene list. One other gene criti-
cal for cholesterol biosynthesis, HMG-CoA reductase was
present on the array but remained unchanged and QPCR
analysis confirmed that VO had no effect on levels of
HMG CoA reductase mRNA. This is surprising since in
mammals HMG-CoA reductase is regulated directly by
cholesterol levels, by hormonal stimuli, and transcrip-
tionally by SREBPs, and therefore our results suggest some
differences in the regulation of this gene between fish and
mammals. Nevertheless, taken together the effects on
genes of the cholesterol biosynthesis pathway strongly
suggests that salmon fed VO respond to reduced choles-
terol levels in the diet. Although we did not measure cho-
lesterol contents of the diets, a recent report, which
quantifies cholesterol and total sterol levels in the raw
ingredients used to formulate the diets, confirms the defi-
ciency of cholesterol in VO diets [18]. Moreover, it is
known that in vegetable oils the bulk of sterol is present
as sitosterol, stigmasterol, campesterol or brassicasterol
depending on source [19]. These plant sterols are not
taken up by mammals, and indeed inhibit cholesterol
uptake [20] and, although not proven, are unlikely to be
taken up by fish. Therefore one of the major responses of
salmon liver during adaptation to VO is up-regulation of
cholesterol biosynthesis to compensate for deficiencies in
the diet. Importantly, and in contrast to the situation with
HUFA, lower levels of dietary cholesterol were fully com-
pensated for, since no differences were observed in choles-
terol content, in liver or in flesh between fish fed FO or
VOs. From the data presented here the compensation for
reduced dietary cholesterol is due to up-regulation ofPage 8 of 15
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pathways such as decreased bile acid synthesis might also
contribute. It should be noted, however, that this experi-
ment consisted of a 12 week trial but in a longer term trial,
after feeding VO for up to 22 months, both liver choles-
terol and plasma LDL cholesterol were lower compared to
FO [21].
Further to the up-regulation of cholesterol biosynthesis
genes, apoB-100 which is a component of low density
lipoprotein (LDL) required for the transport of cholesterol
from liver to other tissues, also showed increases in
expression level, both from microarray and QPCR meas-
urement. Furthermore, from the microarray results angi-
opoietin-related protein 3 (ANGPTL3) was down-
regulated in VO fed fish. ANGPTL3 is a liver derived factor
which suppresses lipid uptake from LDL by tissues and
promotes fatty acid release from adipocytes [22]. Thus the
reduction in ANGPTL3 observed in salmon fed VO is con-
sistent with the increase in apoB-100 and taken together
indicates increases in lipid transport to tissues from liver
via LDL. Interestingly an apoB-like protein, which is
related but clearly distinct from apoB-100 was down-reg-
ulated in VO fed fish, and a protein which is suggested to
act as an "anti-freeze" in fish blood [23], but which resem-
bles apoA, another lipid transport molecule, is up-regu-
lated in all VO. Several other genes which showed changes
in expression levels in VO fed fish have also been linked
to lipid transport. For example cystatin, which was
increased in all VO fed fish, is involved in tissue lipid
uptake, suggested to be related to its role in controlling
elastin and collagen breakdown in the extracellular matrix
[24]. Notably in this regard there were also decreases, in
two microarray features identified as a collagen subtype,
COL1A3, in all VO fish.
Overall these changes indicate a change in the function of
the liver with respect to cholesterol synthesis and distribu-
tion, with an increase in cholesterol biosynthesis and an
increase the transport processes which distribute choles-
terol from the liver to other tissues. In animals fed normal
cholesterol in the diet, the majority of cholesterol in the
liver, from endogenous or exogenous pathways, is trans-
ported in the bile, as cholesterol or as bile acids, and
thence to the gut where, together with phosphatidylcho-
line, it assists in the uptake of dietary lipid. In this regard,
levels of hepatic phosphatidylcholine and its precursor
phosphatidylserine were one of the few lipid composi-
tional measures to vary between dietary treatments. These
compositional changes might be related to changes in SO
and RO diets of phospholipase D mRNA, which encodes
an enzyme which releases choline from PC. Changes in
bile transport, if occurring, may have consequences for
lipid digestion, uptake and transport in the intestine
which might explain the accumulation of lipid droplets in
intestinal cells previously been observed in salmonids fed
VO [6-8]. Interestingly, similar intestinal lipid accumula-
tion is observed in rodents with deficiencies in bile trans-
port [25].
Also notable from the microarray data was an increase in
mRNA for glycogen phosphorylase (the first step of glyco-
gen utilisation) and also in expression of glucose-6-phos-
phate dehydrogenase. These systems are involved in
NADPH production [26] and suggests that the require-
ment for reducing power for cholesterol and HUFA bio-
synthesis is provided by breakdown of glycogen and up-
regulation of NADPH generating systems. Another
enzyme of importance for biosynthetic NADPH produc-
tion, ME, was also shown to have increased activity in RO
fed fish.
Some reports have indicated an increase in β-oxidation in
VO compared to FO fed fish [27,28]. From our microarray
data we did not see increases in the expression of any
genes linked to mitochondrial β-oxidation, indeed
Table 5: Significantly enriched biological process GO categories in VO fed fish compared to FO fed fish
GO Biological Process Category Genes with GO term in input list Genes with GO term in output list Enrichment p-Value
GO:6629: lipid metabolism 91 5 0.00186
GO:44255: cellular lipid metabolism 72 5 0.000643
GO:6631: fatty acid metabolism 36 3 0.00518
GO:6636: fatty acid 
desaturation
5 3 8.98E-06










GO:6820: anion transport 54 3 0.0159
GO:6414: translational elongation 30 3 0.00307Page 9 of 15
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phorylation (pyrophosphates and phosphate carrier pro-
teins) were decreased. Furthermore, QPCR and enzymic
activity measurement confirmed that CPT1, an important
rate limiting step in mitochondrial β-oxidation, was not
significantly altered by VO feeding. However, it is known
that peroxisomal β-oxidation predominates in salmon
liver [29] and so the mRNA expression level of a critical
enzyme of peroxisomal activity, acyl-CoA oxidase [30]
was also measured. Acyl-CoA oxidase mRNA was
increased in salmon fed the LO and RO diets, and this was
consistent with the increased peroxisomal β-oxidation
observed in fish fed LO and RO.
Of course this experiment represents a "snapshot" of gene
expression 20 hours after final feeding and in liver only.
At different prandial states and in different tissues the
expression of genes for metabolic enzymes may be differ-
ent. For example, shortly after feeding, when energy is in
abundance, it is possible that the pentose phosphate path-
way might be fuelled by gluconeogensis rather than glyco-
gen breakdown, and these differences between FO and VO
diets may be masked. With regard to fatty acid β-oxida-
tion, sea bream exhibit differences in mitochondrial and
peroxisomal activity depending on whether they are
measured at 6 or 24 h after feeding [31].
The microarray data also indicated down-regulation of
PPARγ, although, after QPCR no effect of VO feeding was
apparent. PPARs are critical transcriptional regulators of
lipid metabolism and energy homeostasis, and are
encoded by three genes in mammals known as PPARα,
PPARβ and PPARγ[32]. However, in salmon at six PPAR
genes have so far been discovered and they share consid-
erable homology [33,34]. Therefore it is possible that the
microarray results reflect cross-hybridisation of different,
but related transcripts, although a previous microarray
study has also reported a decrease in PPARγ mRNA fol-
lowing VO feeding in salmon [35]. In general cDNA
microarrays are unlikely to be specific tools for measuring
the expression of multiple closely related genes and this
problem is exacerbated in Atlantic salmon which have
polyploid genomes, often possessing more members
within each gene family than the majority of diploid ver-
tebrates. Similar issues been pointed out for the Δ5 and Δ6
fatty acyl desaturase genes which are 95% identical at the
nucleotide level in salmon [12].
Increased lipid content, which might be an indication of
health problems, in the livers of salmon fed VO has been
observed previously [21,36]. In our study, although there
were no significant increases in hepatic lipid, a trend for
increased lipid was supported by higher TAG and free fatty
acid in VO fed fish and levels of mRNA for a marker for
intracellular lipid accumulation, adipophilin [37], were
Table 6: Gene expression measured by QPCR in the liver of Atlantic salmon fed vegetable oils in comparison to fish oil.
LO SO RO
Expression P value Expression P value Expression P value
Genes changed on array
isopentenyl-diphosphate Δisomerase 3.263 0.007 3.755 0.008 3.313 0.023
fatty acyl Δ6 desaturase 2.809 0.009 3.215 0.025 3.994 0.004
apolipoprotein B-100 1.535 0.029 1.137 0.624 1.416 0.036
PPARγ 1.053 0.805 1.118 0.649 1.122 0.555
Genes not on array (BLAST to ESTs)
Mevalonate kinase 2.158 0.003 2.334 0.027 2.949 0.008
SREBP2 2.563 0.018 2.095 0.057 2.578 0.011
adipophilin 2.836 0.032 3.469 0.032 1.338 0.459
acyl-CoA oxidase 1.432 0.034 1.227 0.343 1.501 0.043
Reference or no change on array
β-actin 0.773 0.318 0.908 0.694 0.794 0.291
EF1α 1.199 0.146 1.115 0.564 1.091 0.456
AJ425111 1.079 0.714 0.988 0.939 1.153 0.338
7-dehydrocholesterol reductase 2.624 0.017 3.319 0.02 3.826 0.009
carnitine palmitoyl transferase 1A 1.125 0.411 1.173 0.403 1.099 0.477
catalase 0.919 0.617 0.972 0.892 1.1 0.495
PPARβ1 0.861 0.605 0.932 0.778 0.93 0.78
PPARβ2 0.737 0.228 0.715 0.166 0.756 0.333
HMG-CoA reductase 1.204 0.136 1.132 0.566 1.097 0.516
short chain alcohol dehydrogenase 1.014 0.936 0.806 0.343 1.035 0.865
The identity of the genes tested is indicated. Those genes which were significantly changed (n = 5 fish per treatment, p ≤ 0.05) in fish fed linseed oil 
(LO), soyabean oil (SO) or rapeseed oil (RO) compared to fish oil are indicated in bold. Expression numbers indicate fold change relative to fish oil.Page 10 of 15
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some VO diets cause increases in hepatic lipid accumula-
tion.
Finally from the microarray results, although not directly
addressed by QPCR or biochemistry, were changes in the
expression of genes involved in RNA and protein process-
ing and turnover. These changes may be a reflection of
changes in cholesterol biosynthetic pathways and in lipid
transport, reflecting a requirement to export cholesterol to
tissues.
Conclusion
In conclusion the present study demonstrates the utility of
transcriptomic tools for studies on non-model commer-
cially important fish species. Although, there were limita-
tions in the statistical power of the design due largely to
the inherent variability amongst recently domesticated
farmed Atlantic salmon, by using appropriate filtering of
microarray data, independent gene expression tests and
biochemical and compositional data we were able to
physiologically anchor a significant proportion of the
gene expression results. This combined approach leads to
the hypothesis that the major lipid metabolic effects of
replacing FO with VO in salmon diets are mediated by
SREBP2, a transcription factor which responds to reduc-
tions in membrane cholesterol level caused by reduced
cholesterol in VO based diets. Furthermore, the applica-
tion of the TRAITS/SGP microarray indicated several genes
significantly altered by vegetable oils which suggest mech-
anisms to explain previously observed health impairment
in VO fed salmon.
Methods
Diets and animals
Four diets (4 mm pellets) with the same basal composi-
tion but coated with four different oils were prepared at
the Skretting Technology Centre, Stavanger, Norway. The
diets were formulated to satisfy the nutritional require-
ments of salmonid fish (U.S. National Research Council
1993), and to contain 33% fat and 47% protein, consist-
ing of fish meal (55%), corn gluten (10%), wheat (8.3%),
oil (26.3%), mineral and vitamin mixes (0.2%) and Caro-
phyl Pink® (0.06%). The oils used were FO (Anchovy oil,
Skretting, Stavanger, Norway), RO (Denofa AS, Fredriks-
tad, Norway), LO (NOBA Vetveredeling B.V., Hamburg,
Germany) and SO (Denofa AS, Fredrikstad, Norway).
Fatty acid and proximate compositions of the experimen-
tal diets are given in Table 7. One thousand Atlantic
salmon post-smolts, average weight 132 g, were distrib-
uted randomly into four 2 × 2 m tanks (250/tank) at the
Nutreco Aquaculture Research Centre, Lerang Research
Station, Stavanger, Norway. In order to measure growth in
individual salmon, twenty fish per tank were PIT-tagged
by implanting a micro-transponder into the peritoneal
cavity. The fish were conditioned to the new environment
for 3 weeks before feeding the experimental diets. During
the conditioning period, the fish received commercial diet
containing FO (Atlantic 4 mm; Skretting). Feed intake was
monitored during this period, and the trial did not start
until appetite was at least 0.8% body weight. After the
conditioning period, the fish were fed the experimental
diets to satiation according to usual procedures at Lerang
Research Station, for a period of 16 weeks. Feed intake was
monitored throughout the trial and waste feed was col-
lected from the effluent water from each tank by a wire
mesh collector and dried. Feed given, waste feed and the
resulting net feed intake were registered daily. The tanks
were supplied with sea water at constant temperature
(7.9°C ± 0.1°C). The oxygen level varied between 8 and
12 ppm, with an average of 9.9 ppm. A photoperiod of 18
h light and 6 h darkness was applied.
Table 7: Proximate composition. (percentage of total weight) 
and fatty acid compositions (percentage of total FA weight) of 
experimental diets
FO LO RO SO
Total Protein 46.9 46.0 48.0 47.0
Total Fat 33.2 33.2 34.3 34.1
Ash 6.7 7.6 7.0 7.8
Moisture 6.2 5.8 5.7 4.5
14:0 7.4 0.9 1.2 0.9
16:0 18.7 7.4 7.0 12.6
18:0 3.9 3.5 1.9 3.1
Total saturated1 30.9 11.6 10.1 16.6
16:1n-7 7.5 0.9 1.3 0.9
18:1n-9 8.8 17.4 47.2 20.8
18:1n-7 2.7 1.0 2.7 1.7
20:12 3.3 1.5 2.8 1.7
22:13 3.5 2.0 2.5 2.0
24:1n-9 0.5 0.2 0.3 0.2
Total monoenes 26.3 23.0 56.8 27.3
18:2 n-6 3.5 14.2 17.8 44.4
CLA (9c,11t) 0.0 0.0 0.0 0.0
CLA (10t,12c) 0.0 0.0 0.0 0.0
20:4 n-6 0.9 0.1 0.1 0.1
Total n-6PUFA4 4.7 14.4 18.0 44.6
18:3 n-3 1.2 44.9 8.1 5.7
18:4 n-3 3.4 0.7 0.8 0.6
20:4 n-3 0.8 0.1 0.1 0.1
20:5 n-3 14.7 2.0 2.5 2.0
22:5 n-3 1.7 0.2 0.2 0.2
22:6 n-3 16.3 2.9 3.4 2.9
Total n-3PUFA 38.1 50.8 15.1 11.5
n-6/n-3 0.12 0.28 1.19 3.89
Total PUFA 42.8 65.2 33.1 56.1
Data are means of duplicate analyses. 1, contains 15:0 and 17:0, 
present in some samples at up to 0.5%; 2, predominantly n-9 isomer; 
3, predominantly n-11 isomer; 4, totals include 18:3n-6, 20:2n-6, 
22:4n-6 and 22:5n-6 present in some samples at up to 0.5%; PUFA, 
polyunsaturated fatty acid.Page 11 of 15
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At the start and end of the trial, all the fish in each tank
were anaesthetised with metacain (50 mg/L) and individ-
ually weighed and measured. At the end of the trial, the 20
fish per dietary treatment were sampled for composi-
tional, enzymatic and gene expression analyses, with three
whole fish frozen immediately on dry ice and subse-
quently stored at -20°C for whole body compositional
(proximate) analyses. The other sampled fish were evis-
cerated and twelve were used for biometric determina-
tions (hepato- and viscero-somatic indices) and for lipid
analyses. Livers were taken from each fish, pooled in four
pools of three fish each, and frozen immediately in liquid
nitrogen. Samples of liver were dissected from the remain-
ing five fish from each dietary treatment and these sam-
ples were individually used for enzymatic, microarray and
quantitative PCR (QPCR) analysis. A portion of each liver
was taken for enzymatic analyses and frozen in liquid
nitrogen. For gene expression analysis, samples of 0.5 g of
fresh tissue were rapidly disrupted in 5 ml of TriReagent
using an Ultra-Turrax homogeniser (Fisher Scientific,
Loughborough, U.K.), and immediately frozen in liquid
nitrogen for storage prior to RNA extraction.
Compositional analyses
Proximate analysis, consisting of moisture content and
lipid and protein content, was undertaken as previously
described [38]. Lipid analyses were conducted on liver
from twelve (four pools of three) fish from each diet and
homogenised into pooled "pates". Total lipid was
extracted from diets or 1 g portions of tissue pates and sep-
aration of lipid classes was performed by high-perform-
ance thin-layer chromatography (HPTLC) and fatty acid
analysis performed as described previously [38].
Enzymatic and metabolic assays
All enzymatic and metabolic assays were carried out on
the same five fish randomly selected from each dietary
treatment. HUFA biosynthesis was determined in liver
microsomes as described by Leaver et al., 2006. Assays of
malic enzyme (ME), carnitine acyltransferase I (CPT1)
and peroxisomal fatty acid β-oxidation in tissue homoge-
nates were carried out on liver homogenates as previously
described [14,38].
Microarray gene expression profiling
Liver was selected as the tissue on which to focus gene
expression studies because of its central role in the integra-
tion and control of nutritional physiology and energy
homeostasis. Total RNA was extracted from the same five
fish from each dietary treatment as used for enzymatic
determinations. RNA was prepared from TriReagent
homogenates as described in the manufacturers protocol
(Sigma). Two separate RNA extracts were prepared from
each sample, one for microarray probe preparation and
the second for QPCR. Each biological replicate was co-
hybridised in a two dye experiment with a single pooled
reference sample. The pooled reference sample comprised
equal amounts of RNA from each of the 20 biological
samples. RNA was reverse transcribed and labelled with
either Cy3 (pooled reference) or Cy5 (FO, RO, SO and LO
fed fish) fluors using the FAIRPLAY II cDNA indirect label-
ling kit (Stratagene) according to the manufacturer's
instructions. Briefly 20 μg total RNA was reverse tran-
scribed after being primed with oligo dT, which incorpo-
rated aminoallyl-dUTP into the newly synthesised cDNA
strand. The RNA template was then hydrolysed using 1 M
NaOH for 15 min and neutralised with 1 M HCl. The
cDNA was precipitated overnight. cDNA pellets were
washed in 80% ethanol and air dried before being resus-
pended in 5 μL 2× coupling buffer (Stratagene FAIRPLAYII
reagent). Once the cDNA had fully dissolved (after at least
30 min) 5 μL of either Cy3 or Cy5 dye was added and the
samples incubated in the dark for 30 min. The Cy3 and
Cy5 dyes (GE Healthcare) were dissolved in DMSO prior
to being added to the coupling buffer. To remove unincor-
porated dye, the labelled cDNA (total volume 10 μL) was
passed through a SpinEX column (Qiagen). Dye incorpo-
ration was assessed by separating 0.5 μL of the sample on
a mini-agarose gel and visualising fluorescent products on
a fluorescence scanner (Typhoon Trio, GE Healthcare).
No microarray pre-hybridisation step was required. For
hybridisation the remainder of each labelled cDNA (7–9
μL; 16–30 pmol each dye) was added to 85 μL hybridisa-
tion buffer (UltraHyb, Ambion), 10 μL poly(A)80 (10 mg
mL-1; Sigma) and 5 μL ultrapure BSA (10 mg mL-1;
Ambion). The hybridisation mixture was heated to 95°C
for 3 min, then cooled to 60°C before being applied to the
microarray (TRAITS/SGP, see section 2.7). Hybridisations
were performed on a Gene TAC Hyb Station (Genomic
Solutions) for 16 h at 45°C. Slides were then automati-
cally washed with 2×SSC, 0.5% SDS for 10 min at 60°C;
0.2×SSC, 0.5% SDS for 10 min at 42°C; and finally 0.2 ×
SSC 10 min at 42°C. Following manual rinsing in isopro-
panol and drying by centrifugation, hybridised slides were
scanned at 10 μm resolution using a Perkin Elmer ScanAr-
ray Express HT scanner. BlueFuse software (BlueGnome)
was then used to identify and quantify features. Following
manual spot editing to remove obvious artefactual fea-
tures and fusion of duplicate spot data (BlueFuse proprie-
tary algorithm), the resulting intensity values and quality
annotations were exported into the GeneSpring GX ver-
sion 7.3.1 (Agilent Technologies) analysis platform. Data
transformation, normalisation and quality filtering were
as follows: 1) all raw spot intensity values less than 0.01
were set to 0.01 to facilitate comparisons of transformed
data; 2) a 'per spot per chip' intensity dependent (Lowess)
normalisation was undertaken using software defaults
(20% smoothing/cutoff 10); 3) data were filtered using a
BlueFuse spot confidence value ≥ 0.2 in ≥ 8 slides andPage 12 of 15
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tures which were below reasonable quality thresholds
Bluefuse uses Bayesian statistical models of the signal and
noise distributions on the slide to estimate the confidence
that should be placed in each result. Similarly Bluefuse
integrates various spot quality parameters (eg circularity,
uniformity etc) to provide a spot quality assessment. This
gave a final list of 11024 genes which were eligible for sta-
tistical analysis and application of ANOVA indicated that
9964 features had sufficient data for testing across all
treatments. Experimental annotations complied fully with
MIAME guidelines [39] and data has been submitted to
the ArrayExpress databank (accession E-TABM-478; [40]).
Atlantic salmon ESTs were tentatively identified using
BLASTX to search the Genbank non-redundant protein
sequence database (all non-redundant GenBank CDS
translations + RefSeq Proteins + PDB + SwissProt + PIR +
PRF databases) applying a cut-off value of ≤ e-10. ESTs
which were not assigned using this procedure were then
compared to the Atlantic salmon DFCI Atlantic salmon
Gene Index http://compbio.dfci.harvard.edu/tgi/tgi
page.html comprising ESTs and ESTs assembled into Ten-
tative Consensus (TC) sequences using BLASTN. TCs or
ESTs showing 99.9% identity over a continuous overlap of
>100 nucleotides were then used to search the Genbank
non-redundant protein sequence database applying a cut-
off value of ≤ e-10.
Quantitative PCR (QPCR)
QPCR was performed using an RNA extract from the same
five animals that had been taken for enzymic and micro-
array analysis. Complementary DNA (cDNA) was synthe-
sized from total salmon hepatic RNA using a
commercially available kit according the manufacturers
instructions (Reverse-iT Max 1st strand synthesis kit,
ABgene). Briefly each reaction of 20 μL contained 1.5 μg
of total RNA, 300 ng of random hexamers and 125 ng of
anchored oligo-dT. Following cDNA synthesis at 42°C for
1 hour reactions were stopped by heating at 75°C for 10
min and cDNA diluted to 500 μL total volume with water.
Real-time PCR was performed using a Quantica machine
(Techne). Quantitative PCR analysis for each gene was
performed in triplicate in a total volume of 20 μL contain-
ing 5 μL cDNA (equivalent to 15 ng of input RNA), 100
nM of each primer and 10 μL of Absolute QPCR SYBR
Green Mix 2× (ABgene). For each target gene, forward and
reverse primers were chosen from the available EST
sequences by using Primer3 software[41]. Target genes
were selected by consideration of microarray data and by
BLAST comparison of Atlantic salmon ESTs deposited in
Genbank with sequences of mammalian genes of interest.
Primer pairs and EST information are provided in Table 8.
Thermal cycling was initiated with incubation at 95°C for
15 min in order to activate the Thermo-Start® DNA
Polymerase present in the mix. After this initial step, forty-
five cycles of PCR were performed. Each PCR cycle con-
sisted of heating for 15 s at 95°C for denaturing, and then
for 15 s at 60°C and 30 s at 72°C for annealing and exten-
sion. Cycle threshold (CT) values corresponded to the
Table 8: Genes, accession numbers and primers used for quantitative PCR
Acc No Forward primer Reverse Primer
Genes from Array
isopentenyl-diphosphate Δisomerase 1 CK875291 ACAGCCCTATGGTTATGTGTCATCTC CAAGGTGAGGCGAATGTTTGAAC
7-dehydrocholesterol reductase DW561983 CTTCTGGAATGAGGCATGGT ACAGGTCCTTCTGGTGGTTG
HMG-CoA reductase BE518590 CCTTCAGCCATGAACTGGAT TCCTGTCCACAGGCAATGTA
Δ6 desaturase AY458652 CCCCAGACGTTTGTGTCAG CCTGGATTGTTGCTTTGGAT
apolipoprotein B-100 EG648437 GCTGTGGCTTTAATCCTTGC CCATGGTGTCAGTGATCAGG
catalase CK874978 CAACCCCCAGACTCACCTAA GAAGGTGTGAGAGCCGTAGC
carnitine palmitoyl transferase 1A AM230810 CCTGTACCGTGGAGACCTGT CAGCACCTCTTTGAGGAAGG
short chain alcohol dehydrogenase CK884238 TCTGCACACGAGAGGCATAC GTCAGGGCAGTCACAGCATA
PPARβ1 AJ416953 GACCACCAACCCCAATGGCTCGGAT CAGCCCATTCTCAGCCTGGCACAAG
PPARβ2 AM229303 CCCCCACCATCTTGGTGGCTCAGAC TAGACCACTCTCTGCTTGCCACAGG
PPARγ AJ416951 ACCCAGGAACCCAGAGTCAGCGGAC TTTATAAAGTACTGACCCGCCGTCA
Genes not on array (BLAST to ESTs)
Mevalonate kinase DY708590 CCCTTAATCAGGGTCCCAAT GGTGCTGGTTGATGTCAATG
SREBP2 DY733476 GACAGGCACAACACAAGGTG CAGCAGGGGTAAGGGTAGGT
adipophilin BM413877 GCAGACATGGAAGTCGTTGA ATGGAAATTTGTGGCTCCAG
acyl-CoA oxidase DW555420 AAAGCCTTCACCACATGGAC TAGGACACGATGCCACTCAG
Reference (no change in array ept)
β-actin AF012125 ACATCAAGGAGAAGCTGTGC GACAACGGAACCTCTCGTTA
EF1α AF321836 CTGCCCCTCCAGGACGTTTACAA CACCGGGCATAGCCGATTCC
unknown AJ425111 AGCCTATGACCAACCCACTG TGTTCACAGCTCGTTTACCGPage 13 of 15
(page number not for citation purposes)
BMC Genomics 2008, 9:299 http://www.biomedcentral.com/1471-2164/9/299number of cycles at which the fluorescence emission
monitored in real time exceeded the threshold limit.
Melting curve analysis was performed to indicate the pro-
duction of a single product in these reactions. Standard
curves were established for each gene by plotting CT val-
ues against the log10 of five different dilutions (in tripli-
cate) of cDNA sample solutions. In addition a subset of
randomly selected samples generated by each primer pair
was analysed by agarose gel electrophoresis and sequenc-
ing to confirm the identity of amplicons. Real-time effi-
ciency was determined for each gene from the slopes given
by Quantsoft software, applying the equation E = 10(-1/
slope). The calculated relative expression ratio of each gene
was based on the PCR efficiency (E) and CT of sample
compared with control, and expressed in comparison to
the reference genes, glyceraldehyde phosphate dehydroge-
nase (GAPDH), β-actin, and unidentified EST Acc No.
AJ425111 (REST© software, [42]). Statistically significant
differences in gene expression between the control (FO)
and samples (LO, SO and RO) were evaluated in group
means by randomization tests [43] using REST© software.
Five thousand random allocations were applied and dif-
ferences were considered to be significant at P ≤ 0.05.
Materials
Materials for enzyme assays: [1-14C] Palmitoyl CoA (50–
55 mCi/mmol) and [methyl-3H} L-carnitine (60–86 Ci/
mmol) were obtained from GE Healthcare. BHT, Carni-
tine, coenzyme A, DTT, FAF-BSA, glutathione, HEPES,
KCN, malate, N-acetylcysteine, NADH, NADP, nicotina-
mide, palmitoyl-CoA, perchloric acid, silver nitrate and
TriReagent were obtained from Sigma.
Materials for lipid analyses: HPTLC (10 cm × 10 cm × 0.15
mm) and TLC (20 cm × 20 cm × 0.25 mm) plates, pre-
coated with silica gel 60 (without fluorescent indicator)
were obtained from Merck. All solvents were HPLC grade
and were obtained from Fisher Scientific.
Microarrays: the TRAITS/SGP Atlantic salmon microarray
comprised 16950 minimally redundant, duplicate cDNA
clones and has been described elsewhere [12,44].
Statistical analysis
Unless otherwise stated, all data are presented as means ±
SD (n value as stated). The effects of dietary treatment on
biometry, composition and enzyme activity were analysed
by one-way analysis of variance (ANOVA) followed,
where appropriate, by Tukey's comparison test. Percent-
age data and data which were identified as non-homoge-
neous (Bartlett's test) were subjected to arcsine
transformation before analysis. Differences were regarded
as significant when P ≤ 0.05. Statistical treatment of
microarray and QPCR data is described within the specific
Methods and Results sections.
The probability that a particular biological process GO
term was enriched in the input GO list (All GO annota-
tions in the TRAITS-GS array) compared to the output GO
list (all GO annotations in the experimentally altered gene
list) was calculated using a hypergeometric distribution
model as implemented by GeneSpring GX 7.3.1. The GO
annotation of the TRAITS-GS microarray has been
described by Taggart et al., 2008 [12]
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